Future studies using PPARα transgenic mice to model ischemic stroke may consider monitoring physiological and biochemical variables, such as lipid profiles, glucose levels, and liver function, to better assess how the metabolic consequences of PPARα modulation may affect stroke pathophysiology. Here, PPARA is linked to stroke disorder.